Antibiotic Treatment for Nasal Abscess Caused by S. pyogenes or MRSA
For a nasal abscess that may be caused by S. pyogenes or MRSA, the optimal treatment is a combination of surgical drainage plus amoxicillin-clavulanate (875/125 mg twice daily) with doxycycline (100 mg twice daily) for 5-7 days.
Treatment Algorithm
First-line therapy:
Surgical intervention:
- Incision and drainage is the primary treatment for any abscess
- Culture the purulent material for definitive pathogen identification
Empiric antibiotic therapy (pending culture results):
- Amoxicillin-clavulanate 875/125 mg twice daily PLUS doxycycline 100 mg twice daily
- This combination provides coverage for both S. pyogenes and MRSA, as well as anaerobes
For patients with severe penicillin allergy:
- Clindamycin 300-450 mg three times daily
- Provides excellent coverage for both S. pyogenes and MRSA (approximately 90% of isolates) 1
- Also effective against anaerobes commonly found in nasal abscesses
For severe infections requiring IV therapy:
- Vancomycin 15-20 mg/kg IV every 8-12 hours
- First-line option for severe infections with Grade A-I recommendation 1
- Monitor trough levels to ensure adequate dosing while minimizing nephrotoxicity
Special Considerations
MRSA Risk Factors:
- Previous MRSA infection or colonization
- Recent antibiotic use (within 4-6 weeks)
- Injection drug use
- Systemic inflammatory response syndrome (SIRS)
- Immunocompromised status
Important Clinical Pearls:
- Nasal abscesses can lead to serious complications if not properly treated, including intracranial spread and cosmetic deformity 2
- Reassess within 48-72 hours to ensure clinical improvement
- If no improvement is observed, consider:
- Broadening antibiotic coverage
- Repeat surgical drainage
- Evaluation for underlying conditions
Common Pathogens in Nasal Abscesses:
- Staphylococcus aureus (including MRSA) 2
- Beta-hemolytic streptococci (including S. pyogenes)
- Anaerobic bacteria (including oral flora in some cases) 3
Evidence Strength
The recommendation for combination therapy with amoxicillin-clavulanate plus doxycycline is supported by the Infectious Diseases Society of America guidelines 4 and recent clinical practice guidelines 1. This combination provides optimal coverage against the most likely pathogens while minimizing the risk of treatment failure due to resistant organisms.
While clindamycin has shown remarkable effectiveness in some case reports of nasal septal abscesses 5, increasing resistance rates limit its use as monotherapy unless the patient has a severe penicillin allergy.
The importance of surgical drainage cannot be overstated, as antibiotics alone are insufficient for abscess treatment. This dual approach of drainage plus appropriate antibiotics offers the best chance for clinical cure while preventing complications.